Aldevron

In the Know: Healthcare News for June 29, 2020

preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatment FDA Approves First-Of-Its-Kind Percept™ PC Neurostimulator with BrainSense™ Technology Minnesota business groups oppose visa suspensions for foreign workers Blue Cross first MN health plan with role for expert guidance for gender care Cryosa Raises $8.25M in Fresh Financing Round 20 medical […]

Kevin Ballinger to Assume CEO Role at Aldevron; Michael Chambers to become Executive Chairman

FARGO, N.D. (June 24, 2020) – Attracting one of med-tech’s most accomplished executives, Aldevron has named Kevin Ballinger as Chief Executive Officer, effective July 13, 2020. Aldevron’s co-founder, Michael Chambers, has been named Executive Chairman of the board. Chambers initiated the transition to allow him to focus on innovation, corporate strategy and working with clients […]

In the Know: Healthcare News for May 18, 2020

Medtronic receives US FDA approval for Cobalt and Crome implantable ICDs Boston Scientific prices $1.7b offering Minnesota Blues CEO Craig Samitt on COVID-19, 2021 Rates Increases, Telehealth, Medicare for all, and WFH Smiths Medical Acquires the Business of Access Scientific, LLC, Expanding Vascular Access Offering Minnesota Masons give $35 million to the University of Minnesota […]

In The Know: Healthcare News for March 16, 2020

Mayo Clinic rolls out COVID-19 test CHF Solutions looks to bring its tech to help COVID-19 patients Mayo Clinic starts drive-thru testing for COVID-19 Our Commitment During the COVID-19 Pandemic Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development University of Minnesota to test three drugs for […]

In the Know: Healthcare News for Nov. 4, 2019

Bio-Techne will open $40M+ facility in St. Paul IBM, Mayo Clinic, Geisinger among 25 finalists for $1.6M CMS artificial intelligence challenge Medtronic wins FDA breakthrough nod for fully implantable LVAD Minnesota Startups Raised $70.8M in Q3 Boston Sci Gives Update on the Measured Launch of Lotus Edge Meet The Most Disruptive MBA Startups Of 2019 […]

Aldevron, Nature Technology Corporation Team Up to Offer Nanoplasmids™ for Gene Therapy Manufacturing

FARGO, N.D. (October 22, 2019) – Aldevron has announced the immediate availability of Nanoplasmids™ and antibiotic-free RNA-OUT technology for use in gene therapy manufacturing.  Through a license agreement with Nature Technology Corporation (NTC), Aldevron can now provide its clients the option of using NTC’s plasmid technology to provide a more efficient system for manufacturing viral […]

Medical Alley Q3 Investment and Ecosystem Report

Medical Alley is the global epicenter of health innovation and care. Companies that succeed here change the face of healthcare as we know it, building great businesses and powering Minnesota’s economy along the way. This ecosystem is more than just a cradle for early-stage companies or the sole domain of established market-leaders, it is a […]

In the Know: Healthcare News for August 27, 2019

Blue Cross and Blue Shield of Minnesota to drop insulin co-pay to $0 CVRx Receives FDA Approval for World’s First Heart Failure Neuromodulation Device Q&A: ‘The key is going to be providing information that’s actually helpful’ U.S. health care system must adopt nimbler, more transparent model Starkey Hearing Technologies Named Stevie Awards Winner New cancer […]

EQT to Acquire Majority Interest in Aldevron – the Leading Global Supplier of Plasmid DNA Used in Cell and Gene Therapies

EQT to partner with founder and CEO Michael Chambers, as well as TA Associates, to support Aldevron on its future growth journey EQT will support Aldevron through investments in additional production capacity, R&D, and growth initiatives and by leveraging EQT’s strong healthcare expertise, global presence, and network of Industrial Advisors New York, NY – July […]

Aldevron to Build 14-Acre Gene Therapy Manufacturing Campus

August ground breaking of second GMP manufacturing facility Expands GMP and GMP SourceTM plasmid capacity 10-fold Supports gene editing, gene therapy, and cell therapy applications Includes synthetic production of nucleic acids, vertical integration for clients FARGO, N.D. (June 3, 2019) – Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies; announced […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER